Evaluation of Antipyretic Activity of Olax Scandens (Roxb.) Stem Bark

Authors

  • Raghavendra Naik IPGT & RA Gujarat Ayurved University, Jamnagar, Gujarat, India
  • Sneha D. Borkar IPGT & RA Gujarat Ayurved University, Jamnagar, Gujarat, India
  • R. N. Acharya IPGT & RA Gujarat Ayurved University, Jamnagar, Gujarat, India
  • Mukesh Nariya IPGT & RA Gujarat Ayurved University, Jamnagar, Gujarat, India

Abstract

 

Traditionally, the decoction of Olax scandens (Roxb.) stem bark is used to cure fever and cough. The present experimental study was carried out to evaluate the antipyretic activity of stem bark of Olax scandens (Roxb.) on experimental animals. Brewer’s yeast was used as a pyrogen in Wistar strain albino rats for inducing pyrexia. The stem bark powder, at a dose of 540 mg/kg body weight of rat was suspended in distilled water and administered orally with the help of an oral feeding cannula. The result shows that Olax scandens stem bark powder produced non-significant decrease in rectal temperature after 6 h and non-significant but marked decrease in rectal temperature after 9 h in Brewer’s yeast-induced pyrexia. The result of the study confirms the traditional claim of antipyretic property of Olax scandens (Roxb.) stem bark.

 

Keywords: Antipyretic, Badru, Leafy vegetables, Olax scandens (Roxb.)

Cite the Article

Naik Raghavendra, Borkar Sneha D, Acharya RN, et al. Evaluation of Antipyretic Activity of Olax Scandens (Roxb.) Stem Bark. Research & Reviews: Journal of Pharmacology. 2015; 5(1): 15–18p.

Downloads

Published

2019-07-20

Issue

Vol. 5 No. 1 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.